Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Galmed Pharmaceutica
(NQ:
GLMD
)
3.240
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Galmed Pharmaceutica
< Previous
1
2
3
4
Next >
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
Today 11:05 EST
A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biotech stocks joined the top 10.
Via
Benzinga
Topics
Government
Exposures
Political
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
October 02, 2024
A look at the 20 most searched tickers on Benzinga Pro, which includes many familiar names and some penny stocks that may be less familiar.
Via
Benzinga
MarketBeat Week in Review – 9/16 - 9/20
September 21, 2024
Stocks got a boost as the Federal Reserve cut interest rates, but investors should expect more volatility as economic data continues to deliver mixed signals
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
September 20, 2024
The Benzinga Stock Whisper Index looks at five stocks seeing increased attention from readers and what could be ahead.
Via
Benzinga
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
September 20, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVS),(NYSE:MRK),(NYSE:PFE),(NASDAQ:GLMD) EQNX::TICKER_END
Via
FinancialNewsMedia
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
September 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Galmed Pharmaceuticals Stock Is Soaring Thursday: Here's Why
September 19, 2024
Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) shares are surging Thursday after the company announced plans to broaden its drug development activities over the next two years.
Via
Benzinga
US Stocks Mixed; General Mills Posts Upbeat Earnings
September 18, 2024
Via
Benzinga
Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
September 18, 2024
Via
Benzinga
Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion?
September 17, 2024
Galmed Pharmaceuticals (NASDAQ: GLMD) stock skyrocketed nearly 400%, trading over 80 million shares, compared to its average of 75,000.
Via
MarketBeat
Gold Edges Lower; US Homebuilder Sentiment Rises For September
September 17, 2024
Via
Benzinga
Crude Oil Gains Over 1%; US Business Inventories Increase In July
September 17, 2024
Via
Benzinga
Exposures
Fossil Fuels
Nasdaq Surges 100 Points; US Retail Sales Beat Estimates
September 17, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
September 17, 2024
Via
Benzinga
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
August 22, 2024
Via
Benzinga
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
August 21, 2024
Via
Benzinga
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
July 09, 2024
Via
Benzinga
GLMD Stock Earnings: Galmed Pharmaceuticals Reported Results for Q1 2024
June 22, 2024
Galmed Pharmaceuticals just reported results for the first quarter of 2024.
Via
InvestorPlace
Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
June 10, 2024
Via
Benzinga
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
April 10, 2024
Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 10, 2024
Pre-market stock movers are worth diving into on Wednesday morning to get ready for all of the hottest news moving shares today!
Via
InvestorPlace
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024
April 10, 2024
Explore three penny stocks primed for significant growth, backed by Strong Buy ratings from Wall Street. Play it high-risk.
Via
InvestorPlace
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 08, 2024
Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on...
Via
Benzinga
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
April 08, 2024
Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of...
Via
Benzinga
GLMD Stock Earnings: Galmed Pharmaceuticals Misses EPS for Q4 2023
April 05, 2024
GLMD stock results show that Galmed Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
March 17, 2024
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.
Via
The Motley Fool
Gold Rises 1%; Hibbett Shares Spike Higher
November 21, 2023
U.S. stocks traded lower toward the end of trading on Tuesday following the release of FOMC minutes. The Dow traded down 0.17% to 35,092.02 while the NASDAQ fell 0.59% to 14,200.33. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 21, 2023
Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the...
Via
Benzinga
Nasdaq Falls Over 100 Points; Burlington Shares Jump After Q3 Results
November 21, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Tuesday. The Dow traded down 0.25% to 35,062.35 while the NASDAQ fell 0.81% to 14,168.79. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Down; Chicago Fed National Activity Index Falls In October
November 21, 2023
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 80 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.25% to 35,062.20 while the NASDAQ...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.